Trial Profile
Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients: Single-centre, Prospective, Observational Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Transplant rejection
- Focus Adverse reactions
- Acronyms PAISPK
- 22 Mar 2018 New trial record